Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 12.39bn | 12.18bn | 11.02bn | 9.94bn | 10.81bn | 9.84bn | 9.09bn |
| Cost of revenue | — | — | — | — | 6.76bn | 6.23bn | 5.57bn |
| Research and development | 440m | 415m | 359m | 359m | — | 331m | 300m |
| Selling, general and administrative | 1.08bn | 1.20bn | 1.02bn | 876m | — | 1.33bn | 924m |
| Operating expenses | 10.18bn | 9.95bn | 8.93bn | 7.99bn | — | 8.97bn | 7.58bn |
| Pre-tax income | 2.20bn | 2.52bn | 2.39bn | 2.25bn | — | 1.89bn | 1.45bn |
| Income tax | 252m | 344m | 388m | 283m | — | 198m | 125m |
| Net income | 1.90bn | 2.16bn | 2.03bn | 1.98bn | 1.90bn | 1.85bn | 1.27bn |
| Earnings per share | 1.82 | 2.04 | 1.91 | 1.85 | 1.76 | 1.71 | 1.16 |
| Earnings per share, diluted | 1.81 | 2.02 | 1.89 | 1.83 | 1.75 | 1.70 | 1.15 |
| Metric | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 10.98bn | 12.39bn | 12.50bn | 10.86bn | 12.41bn | 13.62bn | 13.72bn | 12.11bn |
| Receivables | 12.47bn | 11.77bn | 10.67bn |
| Metric | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.82bn | — | — | 1.51bn | — | — |
| Depreciation and amortisation | 227m | 214m | 219m | 210m |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)
| 10.51bn |
| 9.65bn |
| 9.33bn |
| 8.94bn |
| 8.37bn |
| Inventory | 12.37bn | 11.87bn | 11.67bn | 11.30bn | 10.50bn | 9.76bn | 9.72bn | 9.47bn |
| Current assets | 40.36bn | 40.60bn | 40.07bn | 37.80bn | 37.58bn | 37.64bn | 38.65bn | 37.35bn |
| Goodwill | 9.00bn | 9.06bn | 9.04bn | 9.01bn | 8.70bn | 8.54bn | 8.75bn | 8.86bn |
| Total assets | 128.45bn | 130.17bn | 128.24bn | 125.26bn | 124.12bn | 123.14bn | 126.70bn | 123.19bn |
| Current liabilities | 40.03bn | 38.98bn | 37.20bn | 36.47bn | 34.94bn | 34.39bn | 34.09bn | 32.75bn |
| Short-term debt | 2.10bn | 1.69bn | 2.07bn | 1.89bn | 2.08bn | 2.04bn | 1.68bn | 1.70bn |
| Long-term debt | 18.17bn | 18.81bn | 18.77bn | 17.00bn | 17.49bn | 17.23bn | 18.24bn | 17.97bn |
| Total liabilities | 110.15bn | 111.27bn | 109.22bn | 105.91bn | 104.65bn | 103.58bn | 107.60bn | 104.35bn |
| Equity | 18.06bn | 18.68bn | 18.81bn | 19.14bn | 19.25bn | 19.34bn | 19.10bn | 18.84bn |
| Shares outstanding | 1.04bn | 1.05bn | 1.05bn | 1.06bn | 1.07bn | 1.07bn | 1.08bn | 1.08bn |
| Shares issued | — | 1.46bn | — | — | — | — | — | — |
| 224m |
| 199m |
| Capital expenditure | 331m | — | — | 208m | — | — |
| Investing cash flow | −919m | — | — | −317m | — | — |
| Share buybacks | 2.40bn | — | — | 1.97bn | — | — |
| Financing cash flow | −2.83bn | — | — | −2.28bn | — | — |